Modular Medical Inc (MODD) is not a strong buy at the moment for a beginner investor with a long-term focus. The lack of significant trading trends, weak financial performance, and absence of proprietary trading signals suggest that the stock does not currently present a compelling investment opportunity. However, the company's plans for next-generation insulin delivery technology could provide long-term growth potential, but this is speculative at this stage.
The MACD is positive but contracting, RSI is neutral at 38.495, and moving averages are converging. The stock is trading near its support level (S1: 4.519) with resistance at R1: 5.665. No strong bullish or bearish signals are present.
The company is launching next-generation insulin delivery technology, which could drive long-term growth. The recent direct offering priced at $4.50 per share indicates investor interest and compliance with capital markets.
Weak financial performance with no revenue growth, a net income loss of $7.36 million, and declining EPS (-0.11). The stock has a mixed short-term trend with a 50% chance of minor losses (-0.57%) in the next day.
In Q3 2026, the company reported no revenue growth (0% YoY), a net income loss of $7.36 million (up 53.21% YoY), and a decline in EPS to -0.11 (-15.38% YoY). Gross margin remains at 0%.
No analyst rating or price target changes are available for this stock.
